Physician profile
Robert F Garza
NPI 1841406063
$5,567.52
in general payments reported to CMS, 2019-2025
17 companies · $2,297 in 2025
The $2,297 reported for 2025 was more than what 85% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $705 · 2021: $538 · 2022: $449 · 2023: $570 · 2024: $597 · 2025: $2,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,070 · Honoraria: $1,068 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,070.21 |
| Honoraria | $1,068.00 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $1,557.88 | 2023-2025 | Ecm Patch,Pouch |
| Smith+Nephew, INC. | $1,081.38 | 2019-2025 | Stravix, Oasis, Grafix |
| Abbvie INC. | $535.77 | 2023-2025 | |
| Integra Lifesciences Corporation | $388.91 | 2023-2025 | Durasorb Monofilament Mesh, Integra, Surgimend |
| Biocomposites INC | $345.02 | 2024-2025 | Stimulan |
| Sientra, INC. | $314.40 | 2019-2021 | |
| Allergan, INC. | $309.36 | 2020-2022 | |
| Polynovo North America LLC | $287.77 | 2022-2024 | Novosorb Btm |
| Musculoskeletal Transplant Foundation INC. | $185.52 | 2023-2025 | |
| Merz North America, INC. | $165.45 | 2019 | |
| Stryker Corporation | $126.41 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $105.14 | 2019 | |
| Tela Bio, INC. | $65.69 | 2023-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Baxter Healthcare | $38.95 | 2025 | |
| Aroa Biosurgery Incorporated | $29.92 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $19.42 | 2024 | Celleraterx |
| Access Pro Medical, LLC | $10.53 | 2023 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Garza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.